Literature DB >> 31533117

The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy.

Hea Ree Park1, Su Jung Choi2,3, Eun Yeon Joo4,3, Dae-Won Seo4,3, Seung Bong Hong4,3, Jung-Il Lee3,5, Seung-Chyul Hong3,5, Seunghoon Lee6,7, Young-Min Shon4,3.   

Abstract

Deep brain stimulation (DBS) has provided new treatment options for refractory epilepsy; however, treatment outcomes of DBS in refractory epilepsy patients previously treated with vagus nerve stimulation (VNS) have not been clarified. Herein, treatment outcomes of DBS of the anterior nucleus of the thalamus (ANT-DBS) in patients who had previously experienced VNS failure are reported. Seven patients who had previously experienced VNS failure underwent ANT-DBS device implantation. VNS was turned off before DBS device implantation. Monthly seizure counts starting from baseline to 12-18 months after DBS were analyzed. Five (71.3%) of the 7 patients experienced a >50% reduction of seizure counts after DBS; 1 responder reached a seizure-free status after DBS therapy. Of the 2 nonresponders, 1 subject showed improvement in seizure strength and duration, which lessened the impact of the seizures on the patient's quality of life. This is the first study in which favorable outcomes of ANT-DBS surgery were observed in individual patients with refractory epilepsy who had not responded to prior VNS. Further studies with a larger number of subjects and longer follow-up period are needed to confirm the feasibility of ANT-DBS in patients who have previously experienced VNS failure.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Anterior thalamic nucleus; Deep brain stimulation; Failed vagus nerve stimulation; Neuromodulation; Refractory epilepsy

Mesh:

Year:  2019        PMID: 31533117     DOI: 10.1159/000502344

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  5 in total

1.  Improving the effectiveness of ANT DBS therapy for epilepsy with optimal current targeting.

Authors:  Soila Järvenpää; Kai Lehtimäki; Sirpa Rainesalo; Timo Möttönen; Jukka Peltola
Journal:  Epilepsia Open       Date:  2020-08-09

2.  ASSFN Position Statement on Deep Brain Stimulation for Medication-Refractory Epilepsy.

Authors:  Abhijeet Gummadavelli; Dario J Englot; Jason M Schwalb; Chengyuan Wu; Jorge Gonzalez-Martinez; Joseph Niemat; Jason L Gerrard
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

3.  Probabilistic mapping of thalamic nuclei and thalamocortical functional connectivity in idiopathic generalised epilepsy.

Authors:  Yachin Chen; Nicholas Fallon; Barbara A K Kreilkamp; Christine Denby; Martyn Bracewell; Kumar Das; Emily Pegg; Rajiv Mohanraj; Anthony G Marson; Simon S Keller
Journal:  Hum Brain Mapp       Date:  2021-08-25       Impact factor: 5.038

4.  Neuromodulation for Refractory Epilepsy.

Authors:  Philippe Ryvlin; Lara E Jehi
Journal:  Epilepsy Curr       Date:  2021-12-15       Impact factor: 7.500

5.  Anterior thalamic deep brain stimulation in epilepsy patients refractory to vagus nerve stimulation: A single center observational study.

Authors:  Gadi Miron; Ido Strauss; Itzhak Fried; Firas Fahoum
Journal:  Epilepsy Behav Rep       Date:  2022-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.